Альманах клинической медицины. 2014; : 32-36
АССОЦИАЦИЯ ПОЛИМОРФНОГО МАРКЕРА VAL762ALA ГЕНА ADPRT1 С ХРОНИЧЕСКИМ ГЛОМЕРУЛОНЕФРИТОМ
https://doi.org/10.18786/2072-0505-2014-30-32-36Аннотация
Список литературы
1. Боброва Л.А., Козловская Н.Л., Шкарупо В.В. и др. Влияние генетической формы тромбофилии на клинико-морфологические проявления и характер течения хронического гломерулонефрита//Нефрол. диал. 2010. №1. С.25-33.
2. Новожилова А.П., Плужников H.H., Новиков B.C. Механизмы клеточной гибели//Программированная клеточная смерть/под ред. B.C. Новикова. СПб.: Наука, 1996. С.9-29.
3. Суханова М. В., Лаврик О. И., Ходырева С.Н. Поли(АDР-рибозо)полимераза 1 -регулятор белково-нуклеиновых взаимодействий в процессах, возникающих при генотоксическом воздействии//Молекул. биол. 2004. Т.38. С.5834-5847.
4. Cesarone C.F., Scarabelli L., Scovassi I. et al. Changes in activity and mRNA levels of poly(ADP-ribose) polymerase during rat liver regeneration//Biochim. Biophys. Acta. 1990. V.1087. P.241-246.
5. Dantzer F., Schreiber V., Niedergant C. et al. Involvement of poly(ADP-ribose)polymerase in base excision repair//Biochimie. 1999. V.81. P.69-75.
6. Figueroa J.D., Maiats N., Real F.X. et al. Genetic variation in the base excision repair pathway and bladder cancer risk//Hum. Genet. 2007. V.121. P.233-242.
7. Grande J.P. Mechanisms of progression of renal damage in lupus nephritis: pathogenesis of renal scarring//Lupus. 1998. No.7. P.604-610.
8. Gwinner W., Grone H.J. Role of reactive oxygen species in glomerulonephritis//Nephrol. Dial. Transplant. 2000. V.15. P.1127-1132.
9. Hao B., Wang H., Zhou K. et al. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma//Cancer Res. 2004. V.64. P.4378-4384.
10. Hunley T.E., Julian B.A., Phillips J.A. et al. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy//Kidney Int. 1996. V.49. P.571-577.
11. Li F., Szaby C., Pacher P., Southan G.J. et al. Evaluation of orally active poly(ADP ribose) polymerase inhibitor in streptocin-diabetic rat model of early peripheral neuropathy//Diabetologia. 2004. V.47. P.710-717.
12. Lockett K.L., Hall M.C. Xu J. et al. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function//Cancer Res. 2004. V.64. P.6344-6348.
13. Lovati E., Richard A., Frey B. et al. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease 11 Kidney Int. 2001. V.60. P.46-54.
14. Meisterernst M., Stelzer G., Roeder R.G. Poly(ADP-ribose)polymerase enhances activator-dependent transcription in vitro//Proc. Natl. Acad. Sei. 1997. V.94. P.2261-2265.
15. Minchenko A.G., Stevens M.J., White L. et al. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP ribose) polymerase activation//FASE В J. 2003. V.17. P.1514-1516.
16. Pacher P., Liaudet L., Bai P. et al. Activation of poly (ADP ribose) polymerase contributes to the development of doxorubicin-induced heart failure//J. Pharmacol. Exp. Ther. 2002. V.300. P.862-867.
17. Prasad P., Tiwari A.K., Kumar K.M. et al. Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes//BMC Med. Genet. 2010. V.U. P.52.
18. Song J., Narita I., Goto S. et al. Gender specific association of aldosterone synthase gene polymorphism with renal survival in patients with IgA nephropathy//J. Med. Genet. 2003. V.40. P.372-376.
19. Szaby E., Kern T.S., Virag L. et al. Evidence for poly(ADP ribose) polymerase activation in the diabetic retina//FASEB J. 2001. V.15. P.A942.
20. Szaby G., Bahrle S., Stumpf N. et al. Poly(ADP ribose) polymerase inhibition reduces reperfusion injury after heart transplantation//Circ. Res. 2002. V.90. P.100-106.
21. Wang Y., Kikuchi S., Suzuki H. et al. Endothelial nitric oxide synthase gene polymorphism in intron 4 affects on the progression of renal failure in non-diabetic renal disease//Nephrol. Dial. Transplant. 1999. V.14. P.2898-2902.
22. Zhang Q., Li Y., Li X. et al. PARP-1 Val762Ala polymorphism, CagA+ H. pylori infection and risk for gastric cancer in Han Chinese population//Мої. Biol. Rep. 2009. V.36. P.1461-1467.
23. Zhang X., Miao X., Liang G. et al. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer//Cancer Res. 2005. V.65. P.722-726.
24. Zingarelli B., Salzman A.L., Szaby C. Genetic disruption of poly(ADP ribose)synthetase inhibits the expression of P-selectine and intercellular adhesion molecule-1 in myocardial ischemia-reperfusion injury//Circ. Res. 1998. V.83. P.85-94.
Almanac of Clinical Medicine. 2014; : 32-36
POLYMORPHISM OF CHRONIC GLOMERULONEPHRITIS ASSOCIATION WITH ADPRT1 GENE VAL762ALA
https://doi.org/10.18786/2072-0505-2014-30-32-36Abstract
References
1. Bobrova L.A., Kozlovskaya N.L., Shkarupo V.V. i dr. Vliyanie geneticheskoi formy trombofilii na kliniko-morfologicheskie proyavleniya i kharakter techeniya khronicheskogo glomerulonefrita//Nefrol. dial. 2010. №1. S.25-33.
2. Novozhilova A.P., Pluzhnikov H.H., Novikov B.C. Mekhanizmy kletochnoi gibeli//Programmirovannaya kletochnaya smert'/pod red. B.C. Novikova. SPb.: Nauka, 1996. S.9-29.
3. Sukhanova M. V., Lavrik O. I., Khodyreva S.N. Poli(ADR-ribozo)polimeraza 1 -regulyator belkovo-nukleinovykh vzaimodeistvii v protsessakh, voznikayushchikh pri genotoksicheskom vozdeistvii//Molekul. biol. 2004. T.38. S.5834-5847.
4. Cesarone C.F., Scarabelli L., Scovassi I. et al. Changes in activity and mRNA levels of poly(ADP-ribose) polymerase during rat liver regeneration//Biochim. Biophys. Acta. 1990. V.1087. P.241-246.
5. Dantzer F., Schreiber V., Niedergant C. et al. Involvement of poly(ADP-ribose)polymerase in base excision repair//Biochimie. 1999. V.81. P.69-75.
6. Figueroa J.D., Maiats N., Real F.X. et al. Genetic variation in the base excision repair pathway and bladder cancer risk//Hum. Genet. 2007. V.121. P.233-242.
7. Grande J.P. Mechanisms of progression of renal damage in lupus nephritis: pathogenesis of renal scarring//Lupus. 1998. No.7. P.604-610.
8. Gwinner W., Grone H.J. Role of reactive oxygen species in glomerulonephritis//Nephrol. Dial. Transplant. 2000. V.15. P.1127-1132.
9. Hao B., Wang H., Zhou K. et al. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma//Cancer Res. 2004. V.64. P.4378-4384.
10. Hunley T.E., Julian B.A., Phillips J.A. et al. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy//Kidney Int. 1996. V.49. P.571-577.
11. Li F., Szaby C., Pacher P., Southan G.J. et al. Evaluation of orally active poly(ADP ribose) polymerase inhibitor in streptocin-diabetic rat model of early peripheral neuropathy//Diabetologia. 2004. V.47. P.710-717.
12. Lockett K.L., Hall M.C. Xu J. et al. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function//Cancer Res. 2004. V.64. P.6344-6348.
13. Lovati E., Richard A., Frey B. et al. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease 11 Kidney Int. 2001. V.60. P.46-54.
14. Meisterernst M., Stelzer G., Roeder R.G. Poly(ADP-ribose)polymerase enhances activator-dependent transcription in vitro//Proc. Natl. Acad. Sei. 1997. V.94. P.2261-2265.
15. Minchenko A.G., Stevens M.J., White L. et al. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP ribose) polymerase activation//FASE V J. 2003. V.17. P.1514-1516.
16. Pacher P., Liaudet L., Bai P. et al. Activation of poly (ADP ribose) polymerase contributes to the development of doxorubicin-induced heart failure//J. Pharmacol. Exp. Ther. 2002. V.300. P.862-867.
17. Prasad P., Tiwari A.K., Kumar K.M. et al. Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes//BMC Med. Genet. 2010. V.U. P.52.
18. Song J., Narita I., Goto S. et al. Gender specific association of aldosterone synthase gene polymorphism with renal survival in patients with IgA nephropathy//J. Med. Genet. 2003. V.40. P.372-376.
19. Szaby E., Kern T.S., Virag L. et al. Evidence for poly(ADP ribose) polymerase activation in the diabetic retina//FASEB J. 2001. V.15. P.A942.
20. Szaby G., Bahrle S., Stumpf N. et al. Poly(ADP ribose) polymerase inhibition reduces reperfusion injury after heart transplantation//Circ. Res. 2002. V.90. P.100-106.
21. Wang Y., Kikuchi S., Suzuki H. et al. Endothelial nitric oxide synthase gene polymorphism in intron 4 affects on the progression of renal failure in non-diabetic renal disease//Nephrol. Dial. Transplant. 1999. V.14. P.2898-2902.
22. Zhang Q., Li Y., Li X. et al. PARP-1 Val762Ala polymorphism, CagA+ H. pylori infection and risk for gastric cancer in Han Chinese population//Moї. Biol. Rep. 2009. V.36. P.1461-1467.
23. Zhang X., Miao X., Liang G. et al. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer//Cancer Res. 2005. V.65. P.722-726.
24. Zingarelli B., Salzman A.L., Szaby C. Genetic disruption of poly(ADP ribose)synthetase inhibits the expression of P-selectine and intercellular adhesion molecule-1 in myocardial ischemia-reperfusion injury//Circ. Res. 1998. V.83. P.85-94.
